Literature DB >> 24840928

Preparation and solidification of redispersible nanosuspensions.

Xin Zhang1, Jian Guan1, Rui Ni1, Luk Chiu Li2, Shirui Mao3.   

Abstract

To test the feasibility of preparing redispersible powders from nanosuspensions without further addition of drying protectants, Lovastatin was processed into nanosuspensions and subsequently converted into a powder form using a spray-drying process. The effects of spray-drying process parameters and stabilizers on the properties of the spray-dried powders were evaluated. The inlet air temperature was found to have the most pronounced impact; a low-inlet air temperature consistently yielded dried powders with improved redispersibility. This was attributed to the low Peclet number associated with a low-inlet air temperature, making nanoparticles less prone to aggregation and coalescence during spray drying, as evidenced by the well-defined boundary shown between nanoparticles in the SEM photomicrographs of the spray-dried microparticles. The influence of atomization pressure is significant particularly at a low-inlet air temperature. The redispersibility index value of the powder is dependent on the type of stabilizers used in the nanosuspension formulation. Spray-dried powders with acceptable redispersibility were prepared with drug concentration as high as 3%. In conclusion, with optimized process parameters and selected stabilizers, spray drying is a feasible process in the solidification of nanosuspensions with high drug loading and acceptable redispersibility.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  Peclet number; dissolution; drying; high-pressure homogenization method; nanosuspensions; nanotechnology; redispersibility; spray drying; stabilization

Mesh:

Substances:

Year:  2014        PMID: 24840928     DOI: 10.1002/jps.24015

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

2.  Transformation of Ritonavir Nanocrystal Suspensions into a Redispersible Drug Product via Vacuum Drum Drying.

Authors:  Barbara V Schönfeld; Ulrich Westedt; Benjamin-Luca Keller; Karl G Wagner
Journal:  AAPS PharmSciTech       Date:  2022-05-09       Impact factor: 3.246

3.  Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability.

Authors:  Hany S M Ali; Ahmed F Hanafy; Abdulmalik Alqurshi
Journal:  Int J Nanomedicine       Date:  2019-03-13

4.  Influence of Formulation Parameters on Redispersibility of Naproxen Nanoparticles from Granules Produced in a Fluidized Bed Process.

Authors:  Martin Wewers; Stefan Czyz; Jan Henrik Finke; Edgar John; Bernard Van Eerdenbrugh; Michael Juhnke; Heike Bunjes; Arno Kwade
Journal:  Pharmaceutics       Date:  2020-04-16       Impact factor: 6.321

5.  Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management.

Authors:  Antonella Obinu; Elena Piera Porcu; Sandra Piras; Roberta Ibba; Antonio Carta; Paola Molicotti; Rossana Migheli; Alessandro Dalpiaz; Luca Ferraro; Giovanna Rassu; Elisabetta Gavini; Paolo Giunchedi
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

6.  Influence of the Dispersion Medium and Cryoprotectants on the Physico-Chemical Features of Gliadin- and Zein-Based Nanoparticles.

Authors:  Silvia Voci; Agnese Gagliardi; Maria Cristina Salvatici; Massimo Fresta; Donato Cosco
Journal:  Pharmaceutics       Date:  2022-01-30       Impact factor: 6.321

7.  Evaluation of the Formulation Parameter-Dependent Redispersibility of API Nanoparticles from Fluid Bed Granules.

Authors:  Martin Wewers; Jan Henrik Finke; Stefan Czyz; Bernard Van Eerdenbrugh; Edgar John; Guido Büch; Michael Juhnke; Heike Bunjes; Arno Kwade
Journal:  Pharmaceutics       Date:  2022-08-13       Impact factor: 6.525

8.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.

Authors:  Sheikh Tasnim Jahan; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2015-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.